Moody’s Investors Service is of the view that India will see strong demand for cement in FY23 and FY24. Read More

Moody’s Investors Service is of the view that India will see strong demand for cement in FY23 and FY24. Read More

Railtel has been performing well this year, bagging three orders so far in 2023, excluding this order.Read More

Railtel has been performing well this year, bagging three orders so far in 2023, excluding this order.Read More

RailTel will continue to eye more such projects to enhance revenue stream, said CMD Sanjai Kumar Shares of Railtel Corporation Read More

RailTel will continue to eye more such projects to enhance revenue stream, said CMD Sanjai Kumar Shares of Railtel Corporation Read More

Macquarie has an underperform rating on the stock, with the target at Rs 810 a share Macquarie expects Q4 FY23 EBITDA Read More

Macquarie has an underperform rating on the stock, with the target at Rs 810 a share Macquarie expects Q4 FY23 EBITDA Read More

Shares of BEML  rose in early trade on February 17 after the company signed multiple Memorandum of Understandings (MoUs) at Aero Read More

Shares of BEML  rose in early trade on February 17 after the company signed multiple Memorandum of Understandings (MoUs) at Aero Read More

According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Read More

According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Read More

According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Read More

According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy#39;s Labs#39; base EBITDA, and the entry of Read More

According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy’s Labs’ base EBITDA, and the entry of Read More